Get access

Hyperlipidemia: a new therapeutic target for diabetic neuropathy


Andrea M. Vincent, PhD, Department of Neurology, University of Michigan, 5017 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Tel: +1 734-615-8933; Fax: +1 734-763-7275; E-mail:


Abstract Emerging data establish dyslipidemia as a significant contributor to the development of diabetic neuropathy. In this review, we discuss how separate metabolic imbalances, including hyperglycemia and hyperlipidemia, converge on mechanisms leading to oxidative stress in dorsal root ganglia (DRG) sensory neurons. We conclude with suggestions for novel therapeutic strategies to prevent or reverse diabetes-induced nerve degeneration.

Get access to the full text of this article